Improving glycemic control and quality of life in patients with type 2 diabetes (T2D) Nutritional, Metabolic, Endocrine Type 2 diabetes mellitus
Conditions
Interventions
Patients will be randomized to two parallel arms (intervention and control arms) using blocked randomization in a gender-stratified manner.
1. Intervention arm: Addition of a social supporter to the
Sponsors
Swiss Tropical and Public Health Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Having a T2D diagnosed within the 3 months period prior INSP first visit 2. Receiving first prescription of antidiabetic drug from INSP 3. Aged 18 years or older and living in the city of Abidjan 4. Having no plan to move from home for the following 12 months 5. Living with family member or someone in the household 6. Access to a telephone
Exclusion criteria
Exclusion criteria: 1. Severely ill patients requiring hospitalization at first visit 2. Diagnoses of other illnesses not suitable with the study (cancer, severe psychiatric disease/dementia, asthma, spinal cord injury, congestive heart failure) 3. Pregnant or preparing for pregnancy (women only) 4. Unwilling to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c measured using blood test 3 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. HbA1c at baseline, 3 and 12 months 2. Hypoglycemia event profile measured using patient (self-tests) and hospital records after 3 and 12 months 3. Quality of life measured using Depression, Anxiety and Stress Scale-21 (DASS-21) at baseline, 3 and 12 months 4. Mental health status (depression, anxiety and stress) measured using WHO Quality of Life (WHOQOL-BREF) Questionnaire at baseline, 3 and 12 months | — |
Countries
Cote d'Ivoire
Contacts
Public ContactFranck Ekou
Outcome results
None listed